EUVIMEDEUVIMED entdecken
Open Access

Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production

Jing Yang, Xuhui Tong, Wei Wang, Xianjun Yu, Jin Xu, Si Shi

Cellular Oncology · 2024

DOI: 10.1007/s13402-024-01022-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Jing Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Pancreatic Neoplasms, Disease Progression, Carbonic Anhydrase IX. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesPancreatic NeoplasmsDisease ProgressionCarbonic Anhydrase IXHumansAnimalsCell Line, TumorHydrogen-Ion ConcentrationCell ProliferationCarcinoma, Pancreatic DuctalMiceLactic AcidMice, NudeCell MovementCA-19-9 AntigenMice, Inbred BALB CMitochondriaGene Expression Regulation, NeoplasticAntigens, Neoplasm

Stichwörter der Autor:innen

CA9FUSGlycolysisLactatePancreatic cancerROS

Substanzen

Reactive Oxygen SpeciesCarbonic Anhydrase IXLactic AcidCA9 protein, humanCA-19-9 AntigenAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. xujin@fudanpci.org.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. xujin@fudanpci.org.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Tong, X., Wang, W., Yu, X., Xu, J., & Shi, S. (2024). Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Cellular Oncology. https://doi.org/10.1007/s13402-024-01022-9

Vancouver

Yang J, Tong X, Wang W, Yu X, Xu J, Shi S. Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Cellular Oncology. 2024. doi:10.1007/s13402-024-01022-9

BibTeX
@article{Yang2024,
  author = {Yang, Jing and Tong, Xuhui and Wang, Wei and Yu, Xianjun and Xu, Jin and Shi, Si},
  title = {Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-024-01022-9}
}
Kostenlos starten →